Skip to main content
OpenTrials
Completed

NCT Number: NCT01596686

Comparison of Preparation Regimens for Colonoscopy

The investigators intend to study the impact of two different preparation regimens for colonoscopy (PEG vs sodium picosulphate) on the quality of the endoscopy as well as patient tolerability.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Colentina Clinical Hospital, Bucharest, Romania

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • all patients undergoing colonoscopy

Exclusion criteria

  • patient refusal to sign informed consent

Treatment and study plan

one of two possible colon preparation regimens

Drug

Patients are randomized to receive one of the two different preparation regimens for colonoscopy usually employed in our unit, polyethylene glycol or sodium picosulphate and magnesium citrate

Other names: Fortrans, Picoprep

Primary outcomes

  1. colon preparation

    Time frame: 24 h

    the impact of colon preparation as assessed by the endoscopist (scale from 1 to 4, 1 representing the worst and 4 the best prepared colon) on the quality of the endoscopic examination

Sponsors and collaborators

Lead sponsor

Clinical Hospital Colentina

Other

Registry information

Important dates

Study start
2012
Primary completion
2012
Study completion
2013
First posted
May 11, 2012
Registry last updated
Dec 24, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.